International Biotechnology Trust Plc Buys Neurocrine Biosciences Inc, ACADIA Pharmaceuticals Inc, Biohaven Pharmaceutical Holding Co, Sells Immunomedics Inc, ChemoCentryx Inc, Zogenix Inc

• New Purchases: IOVA, PTGX, AUPH, MRSN, CYTK,
• Added Positions: NBIX, ACAD, BHVN, XLRN, BMRN, SGEN, EXEL, SRPT, GILD, BPMC, GBT, ITCI,
• Reduced Positions: IMMU, CCXI, HZNP, BIIB, MRTX, AMGN, ALXN,
• Sold Out: ZGNX, ENTA, SAGE, PRNB, MNTA,

For the details of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's stock buys and sells, go to https://www.gurufocus.com/guru/international+biotechnology+trust+plc/current-portfolio/portfolio

1. Horizon Therapeutics PLC (HZNP) - 389,000 shares, 9.76% of the total portfolio. Shares reduced by 10.37%
2. Neurocrine Biosciences Inc (NBIX) - 221,800 shares, 6.89% of the total portfolio. Shares added by 109.64%
3. Gilead Sciences Inc (GILD) - 321,284 shares, 6.55% of the total portfolio. Shares added by 5.94%
4. ACADIA Pharmaceuticals Inc (ACAD) - 486,000 shares, 6.47% of the total portfolio. Shares added by 59.34%
5. Biomarin Pharmaceutical Inc (BMRN) - 247,584 shares, 6.07% of the total portfolio. Shares added by 33.41%

International Biotechnology Trust Plc initiated holding in Iovance Biotherapeutics Inc. The purchase prices were between $27.75 and $36.3, with an estimated average price of $30.63. The stock is now traded at around $40.65. The impact to a portfolio due to this purchase was 1.54%. The holding were 145,000 shares as of 2020-09-30.

International Biotechnology Trust Plc initiated holding in Protagonist Therapeutics Inc. The purchase prices were between $15.19 and $22.4, with an estimated average price of $18.78. The stock is now traded at around $23.89. The impact to a portfolio due to this purchase was 0.96%. The holding were 152,000 shares as of 2020-09-30.

International Biotechnology Trust Plc initiated holding in Aurinia Pharmaceuticals Inc. The purchase prices were between $13.19 and $16.66, with an estimated average price of $14.49. The stock is now traded at around $14.85. The impact to a portfolio due to this purchase was 0.55%. The holding were 115,000 shares as of 2020-09-30.

International Biotechnology Trust Plc initiated holding in Mersana Therapeutics Inc. The purchase prices were between $16.2 and $25.7, with an estimated average price of $20.18. The stock is now traded at around $25.65. The impact to a portfolio due to this purchase was 0.43%. The holding were 72,000 shares as of 2020-09-30.

International Biotechnology Trust Plc initiated holding in Cytokinetics Inc. The purchase prices were between $20.58 and $28.96, with an estimated average price of $23.4. The stock is now traded at around $17.68. The impact to a portfolio due to this purchase was 0.17%. The holding were 25,000 shares as of 2020-09-30.

International Biotechnology Trust Plc added to a holding in Neurocrine Biosciences Inc by 109.64%. The purchase prices were between $96.16 and $135.15, with an estimated average price of $115.74. The stock is now traded at around $94.75. The impact to a portfolio due to this purchase was 3.6%. The holding were 221,800 shares as of 2020-09-30.

International Biotechnology Trust Plc added to a holding in ACADIA Pharmaceuticals Inc by 59.34%. The purchase prices were between $36.42 and $57, with an estimated average price of $43.24. The stock is now traded at around $56.60. The impact to a portfolio due to this purchase was 2.41%. The holding were 486,000 shares as of 2020-09-30.

International Biotechnology Trust Plc added to a holding in Biohaven Pharmaceutical Holding Co Ltd by 205.33%. The purchase prices were between $59.04 and $77.95, with an estimated average price of $65.57. The stock is now traded at around $87.67. The impact to a portfolio due to this purchase was 1.94%. The holding were 137,400 shares as of 2020-09-30.

International Biotechnology Trust Plc added to a holding in Acceleron Pharma Inc by 294.44%. The purchase prices were between $89.13 and $113.11, with an estimated average price of $99.44. The stock is now traded at around $118.22. The impact to a portfolio due to this purchase was 1.93%. The holding were 71,000 shares as of 2020-09-30.

International Biotechnology Trust Plc added to a holding in Biomarin Pharmaceutical Inc by 33.41%. The purchase prices were between $71.87 and $131.03, with an estimated average price of $101.18. The stock is now traded at around $78.90. The impact to a portfolio due to this purchase was 1.52%. The holding were 247,584 shares as of 2020-09-30.

International Biotechnology Trust Plc added to a holding in Sarepta Therapeutics Inc by 46.51%. The purchase prices were between $127.12 and $172.34, with an estimated average price of $151.84. The stock is now traded at around $144.90. The impact to a portfolio due to this purchase was 0.45%. The holding were 31,500 shares as of 2020-09-30.

International Biotechnology Trust Plc sold out a holding in Zogenix Inc. The sale prices were between $17.5 and $29.36, with an estimated average price of $24.56.

International Biotechnology Trust Plc sold out a holding in Enanta Pharmaceuticals Inc. The sale prices were between $43.36 and $53.53, with an estimated average price of $48.48.

International Biotechnology Trust Plc sold out a holding in Sage Therapeutics Inc. The sale prices were between $41.13 and $62.45, with an estimated average price of $50.58.

International Biotechnology Trust Plc sold out a holding in Principia Biopharma Inc. The sale prices were between $56 and $101.07, with an estimated average price of $88.57.

International Biotechnology Trust Plc sold out a holding in Momenta Pharmaceuticals Inc. The sale prices were between $27.91 and $52.49, with an estimated average price of $41.42.